Related references
Note: Only part of the references are listed.Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
Ronit Mazor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antibody-Mimetic Ligand Selected by mRNA Display Targets DC-SIGN for Dendritic Cell-Directed Antigen Delivery
Liang Xiao et al.
ACS CHEMICAL BIOLOGY (2013)
Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
Eric Tran et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Sunitha Kakarla et al.
MOLECULAR THERAPY (2013)
Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors
Meghaan P. Walsh et al.
PLOS ONE (2013)
Fibroblast activation protein A potential therapeutic target in cancer
Rui Liu et al.
CANCER BIOLOGY & THERAPY (2012)
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Melody A. Swartz et al.
CANCER RESEARCH (2012)
Fibroblast Activation Protein in Remodeling Tissues
M. Jacob et al.
CURRENT MOLECULAR MEDICINE (2012)
Therapeutic targets and recent advances in protein immunotoxins
J. Madhumathi et al.
CURRENT OPINION IN MICROBIOLOGY (2012)
Complexities of TGF-β Targeted Cancer Therapy
Erin C. Connolly et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Targeting Carcinoma-Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation Protein-Activated Prodrug
W. Nathaniel Brennen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Rationale Behind Targeting Fibroblast Activation Protein-Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy
W. Nathaniel Brennen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells
Hyung-Ok Lee et al.
BMC CANCER (2011)
Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
Yan Huang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
Pravin Mishra et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging
Zibo Li et al.
THERANOSTICS (2011)
CCL5 Promotes Macrophage Recruitment and Survival in Human Adipose Tissue
Mayoura Keophiphath et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model
Yuan Wen et al.
CANCER SCIENCE (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Substituted 4-Carboxymethylpyroglutamic Acid Diamides as Potent and Selective Inhibitors of Fibroblast Activation Protein
Ting-Yueh Tsai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
Yasushi Kojima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Angelica M. Santos et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
Debbie Liao et al.
PLOS ONE (2009)
On the edge of validation - Cancer protease fibroblast activation protein
Beni B. Wolf et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin
Mitomu Kioi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Engineered lentivector targeting of dendritic cells for in vivo immunization
Lili Yang et al.
NATURE BIOTECHNOLOGY (2008)
Anti-cancer therapies targeting the tumor stroma
Valeska Hofmeister et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer
Kalyani Narra et al.
CANCER BIOLOGY & THERAPY (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
Immunotoxin treatment of cancer
Ira Pastan et al.
ANNUAL REVIEW OF MEDICINE (2007)
Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice
YuJian Zhang et al.
CLINICAL CANCER RESEARCH (2006)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Interleukin-10 and the immune response against cancer: a counterpoint
S Mocellin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
Tumor necrosis factor or tumor promoting factor?
F Balkwill
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions
CF Singer et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Molecular mechanisms of blood vessel growth
EM Conway et al.
CARDIOVASCULAR RESEARCH (2001)
Share Paper
